Abu Dhabi Investment Authority to Acquire 3 Percent stake in Micro Life Sciences
The Abu Dhabi Investment Authority is set to acquire a 3 percent interest in the medical devices company Micro Life Sciences Pvt Ltd (Meril) for $ 200 million.
A fully-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has finalized agreements to invest $ 200 million for a 3 percent share in Meril.
This investment places the company's enterprise value at $ 6.6 billion. The deal is pending approval from the Competition Commission of India (CCI).
Established by the Bilakhia Group, Meril is a pioneer in medical technology (MedTech), concentrating on clinically sophisticated solutions across various specialties—such as Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics, and Surgical Robotics.
Located in Vapi, Meril boasts advanced, vertically integrated, and globally certified manufacturing and R&D facilities spread over a 100-acre MedTech campus.
Also Read: How Tensions Grew Worse between Elon Musk and Donald Trump
The organization employs over 13,000 individuals, operates more than 35 global subsidiaries, and caters to healthcare systems in 150 countries.
"This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions," says Sanjeev Bhatt, Senior Vice President - Strategy at Meril.
Also Read: World Youth Skills Day 2025: Youth Empowerment through AI and Digital Skills
Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Abu Dhabi government through a strategy focused on long-term value creation.